الفهرس 
Additive Value of Positron Emission Mammography (PEM) in Breast Cancer Staging
Abbreviation ListOnly 14 pages are availabe for public view
 |  | from | 121 |  |  |
| | | from | 121 | | |
Abstract
PEM is a new technology specialized for imaging breast tissue. It is considered as a functional modality that involves the use of 18F-fluorodeoxyglucose (FDG) for the detection of glucose metabolism by breast lesions.
The aim of this work was to evaluate the possible benefits that can be obtained from adding the use of functional imaging modality (PEM) with the anatomical imaging modalities sonomammography (SM) in breast imaging. Also, the impacts of these findings on patient management.
The current study included 77 patients with pathology proved 80 malignant lesions as 3 patients had bilateral breast cancer. Seventy-six patients were biopsy-proven breast cancer while one patient had a biopsy from pathologic axillary lymph nodes which revealed metastatic adenocarcinoma of breast origin. PEM was done for about 77 patients. PUVmax and LTB were evaluated for any FDG avid lesion. Results of PEM were correlated with the post-operative pathology results